Pentoxifylline improves the quality of life in type-2 diabetes foot syndrome

OBJECTIVES: To evaluate the effect of pentoxifylline on the quality of life (QoL) in diabetic foot syndrome (DFS) by using Short Form-36 questionnaire, and in reference to the revised neuropathy disability score (RNDS) and grading of diabetic foot. METHODS: This randomized placebo-controlled study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Nimer, Marwan, Ratha, Rawa, Mahwi, Taha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717475/
https://www.ncbi.nlm.nih.gov/pubmed/31489009
http://dx.doi.org/10.12669/pjms.35.5.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717475/
https://www.ncbi.nlm.nih.gov/pubmed/31489009
http://dx.doi.org/10.12669/pjms.35.5.11

Ejemplares similares